Aspen Pharmacare Holdings Limited (JSE:APN)

Stephen Saad
Group CEO
Market Cap (AUD): 63.75B
Sector: Health Care
Last Trade (AUD): 140.6 -2.22 (-1.58%)
Tab Bar

1. About

Aspen Pharmacare Holdings Limited (JSE:APN) is a global specialty and branded pharmaceutical company, improving the health of patients across the world through its high quality and affordable products. Active at every stage of the value chain, Aspen is uniquely diversified by geography, product and manufacturing capability, positioning it well to maximise the value it create for the business and its diverse stakeholders.

Aspen supplies medicines to more than 150 countries and has 70 established business operations in 55 countries. 

The company focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments:

Commercial Pharmaceuticals

Regional Brands – a widely diverse segment comprising predominantly leading domestic brands in the Sub-Saharan Africa, Australasia and Latin American territories.

Sterile Focus Brands – focused on niche, sterile products comprising our Anaesthetics Brands and Thrombosis Brands.

  • Anaesthetics – includes a broad range of general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents.
  • Thrombosis – comprises a broad range of specialist injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors and heparin derivatives.



Contract and supply of chemical and biochemical APIs and finished dose form (“FDF”) pharmaceuticals for third parties

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk